查看文章

Invasive fungal disease (IFD) is a common complication of therapy for acute leukemia. Whilst the efficacy and safety of prophylactic strategies to prevent IFD during induction chemotherapy for acute myeloid leukemia are relatively well defined, very few data are available with respect to IFD incidence in adult acute lymphoblastic leukemia (ALL)[1]. Over the last decade the intensity of induction protocols in adult ALL have increased significantly [2], resulting in increased corticosteroid exposure and prolonged neutropenic episodes, both well-defined risk factors for the development of IFD [3]. Consequently, the adequacy of fluconazole-based prophylactic strategies to prevent IFD during therapy of ALL is increasingly debatable. However, due to the potential for interactions between various chemotherapy agents used in ALL induction and the extended-spectrum azoles [4, 5], fluconazole continues to be used for …